Anatomic Pathology Market: By Product (Services (Cytopathology, Histopathology), Instruments (Slide Strainer, Tissue Processor, Microtomes), Consumables (Antibodies, Reagents)), By Application (Drug Discovery, Diagnosis), By End User (Hospitals, Research Organization, Diagnostic Centres), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Anatomic Pathology Market size was valued at USD 19,739.5 million in 2023 and is poised to grow at a significant CAGR of 8.3% from 2024-2030. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the Anatomic Pathology Market report includes human demographics regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. The anatomic pathology is a branch of science that involves in molecular, biochemical and microscopic analysis of tissues and organs in order to find the effectiveness of diseases. The main objective of anatomic pathology is the identification of abnormalities to manage treatment and diagnosis. This can be helpful diagnosis of different types of cancers. The global anatomic pathology market is surging owing to frequent acquisitions and collaborations by the market players. For instance, In November 2018, Quest Diagnostics, Inc. agreed to acquire the assets of the clinical laboratory services business of Boyce and Bynum Pathology Laboratories or BBPL including anatomic pathology services. Moreover, In December 2018, Sonic Healthcare acquired Aurora Diagnostics to expand its anatomic pathology services in U.S.

Anatomic Pathology Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

8.3%

Largest Market

Asia Pacific

Fastest Growing Market

North America
Anatomic Pathology Market Dynamics

Anatomic Pathology market is driven by growing prevalence of chronic disease, increase in geriatric population, rise in initiatives taken by the government in order to prevent the diseases. Furthermore, rise in incidence of STD’s, changes in lifestyle of people, increase in awareness regarding diseases and their preventive measures are expected to propel the growth of the market. On the other hand, lack of awareness in developing countries, high cost of the process are dampen the anatomic pathology market.Based on end-user, hospitals accounted for larger market revenue share  and projected gain market revenue share over the forecast period. Players focusing on innovation of newer products and collaboration strategies to retain market position in global anatomic pathology market

Key Features of the Reports

  • The anatomic pathology market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Anatomic Pathology Market Segmentation

By Product
  • Services
    • Cytopathology
    • Histopathology
  • Instruments
    • Slide Strainer
    • Tissue Processor
    • Microtomes
  • Consumables
    • Antibodies
    • Reagents
By Application
  • Drug Discovery
  • Diagnosis
By End User
  • Hospitals
  • Research Organization
  • Diagnostic Centres
By Geography
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

The anatomic pathology market size was valued at USD 19,739.5 million in 2023

The anatomic pathology market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA

The anatomic pathology market key players Thermo Fisher Scientific (U.S.), Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Agilent Technologies (U.S.), Quest Diagnostics Incorporated (U.S.), NeoGenomics Laboratories, Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.)

1.Executive Summary
2.Global Anatomic Pathology Market Introduction 
2.1.Global Anatomic Pathology Market  - Taxonomy
2.2.Global Anatomic Pathology Market  - Definitions
2.2.1.Product
2.2.2.Application
2.2.3.End User
2.2.4.Region
3.Global Anatomic Pathology Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Anatomic Pathology Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Anatomic Pathology Market  By Product, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Services
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Instruments
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Consumables
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Anatomic Pathology Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Drug Discovery
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Diagnosis
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Anatomic Pathology Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Research Organization
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Diagnostic Centres
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Anatomic Pathology Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Anatomic Pathology Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Services
9.1.2.Instruments
9.1.3.Consumables
9.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Drug Discovery
9.2.2.Diagnosis
9.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Research Organization
9.3.3.Diagnostic Centres
9.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Anatomic Pathology Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Services
10.1.2.Instruments
10.1.3.Consumables
10.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Drug Discovery
10.2.2.Diagnosis
10.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Research Organization
10.3.3.Diagnostic Centres
10.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Anatomic Pathology Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Services
11.1.2.Instruments
11.1.3.Consumables
11.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Drug Discovery
11.2.2.Diagnosis
11.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Research Organization
11.3.3.Diagnostic Centres
11.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Anatomic Pathology Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Services
12.1.2.Instruments
12.1.3.Consumables
12.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Drug Discovery
12.2.2.Diagnosis
12.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Research Organization
12.3.3.Diagnostic Centres
12.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Anatomic Pathology Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Services
13.1.2.Instruments
13.1.3.Consumables
13.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Drug Discovery
13.2.2.Diagnosis
13.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Research Organization
13.3.3.Diagnostic Centres
13.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Thermo Fisher Scientific (U.S.)
14.2.2.Hoffmann-La Roche AG (Switzerland)
14.2.3.Danaher Corporation (U.S.)
14.2.4.Sakura Finetechnical Co., Ltd. (Japan)
14.2.5.Agilent Technologies (U.S.)
14.2.6.Quest Diagnostics Incorporated (U.S.)
14.2.7.NeoGenomics Laboratories, Inc. (U.S.)
14.2.8.Laboratory Corporation of America Holdings (U.S.)
15. Research Methodology 
16. Appendix and Abbreviations 
  • Thermo Fisher Scientific (U.S.)
  • Hoffmann-La Roche AG (Switzerland)
  • Danaher Corporation (U.S.)
  • Sakura Finetechnical Co., Ltd. (Japan)
  • Agilent Technologies (U.S.)
  • Quest Diagnostics Incorporated (U.S.)
  • NeoGenomics Laboratories, Inc. (U.S.)
  • Laboratory Corporation of America Holdings (U.S.)

Adjacent Markets